Concepedia

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide

Thomas H. Inge, Shelley K. Hoover, James L. Frank, Thomas T. Kawabata, Kevin P. Bethke, Harry D. Bear

Cancer Immunology Immunotherapy · 1992 · 11 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

R J North · The Journal of Experimental Medicine · 1982 · 641 citations · Full text

, , +17

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

P W Askenase, Betty J. Hayden, Richard K. Gershon · The Journal of Experimental Medicine · 1975 · 430 citations · Full text

, , +9

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

Martin Röllinghoff, Anna Starzinski‐Powitz, Klaus Pfizenmaier et al. · The Journal of Experimental Medicine · 1977 · 335 citations · Full text

, , +16

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

P D Greenberg, D E Kern, Martin A. Cheever · The Journal of Experimental Medicine · 1985 · 288 citations · Full text

, , +17

Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.

Michel Awwad, R J North · PubMed · 1989 · 150 citations

, , +15